search
Back to results

Model 20066 Left Ventricular (LV) Lead Study

Primary Purpose

Heart Failure

Status
Completed
Phase
Phase 1
Locations
International
Study Type
Interventional
Intervention
Pacing Lead
Sponsored by
Medtronic Cardiac Rhythm and Heart Failure
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient meets CRT inclusion criteria as determined by local regulatory and/or hospital policy
  • Patient has signed and dated the study-specific informed consent form
  • Patient is 18 years of age or older
  • Patient is expected to remain available for follow-ups at the investigational center
  • Patient is willing and able to comply with protocol

Exclusion Criteria:

  • Patient has a previous complete atrial based biventricular CRT system
  • Patient has a previous LV lead implanted or previous implant attempt within 30 days of implant or ongoing Adverse Events from previous unsuccessful attempt
  • Patient has known coronary venous vasculature that is inadequate for lead placement
  • Patient has unstable angina pectoris or has had an acute myocardial infarction (MI) within the past month
  • Patient has had a coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the past three months
  • Patient has chronic (permanent) atrial arrhythmias
  • Patient has contraindications for standard transvenous cardiac pacing (e.g., mechanical right heart valve)
  • Patient has had a heart transplant (patients waiting for heart transplants are allowed in the study)
  • Patient is enrolled in any concurrent drug and/or device study that may confound the results of this study
  • Patient has a terminal illness and is not expected to survive more than three months
  • Patient meets exclusion criteria required by local law (e.g. age, incompetence, pregnancy, breast feeding, etc).
  • Patient is unable to tolerate an urgent thoracotomy

Sites / Locations

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

20066 Lead

Arm Description

Non-randomized study. Intervention: Device: Pacing Lead

Outcomes

Primary Outcome Measures

Number of implant procedure related and lead-related complications in the first month post-implant

Secondary Outcome Measures

Success rate of the Model 20066 lead
Cannulation time
Fluoroscopy Time
Model 20066 Lead Placement Time
Total Implant Time
Assessment of Lead Handling Characteristics
Electrical Performance-Tip Electrode: LV Voltage Threshold
Electrical Performance -Tip Electrode: Sensing
Electrical Performance -Tip Electrode: Pacing Impedance
Electrical Performance -Ring Electrode: LV Voltage Threshold
Electrical Performance -Ring Electrode: Sensing
Electrical Performance -Ring Electrode: Pacing Impedance
Summarize All Adverse Events
Summarize Final 20066 Lead Position

Full Information

First Posted
May 25, 2011
Last Updated
October 10, 2016
Sponsor
Medtronic Cardiac Rhythm and Heart Failure
search

1. Study Identification

Unique Protocol Identification Number
NCT01365234
Brief Title
Model 20066 Left Ventricular (LV) Lead Study
Official Title
Model 20066 Left Ventricular (LV) Lead Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
July 2011 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
December 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medtronic Cardiac Rhythm and Heart Failure

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed. CRT is similar to a pacemaker. It is placed (implanted) under the skin of the upper chest. CRT is delivered as tiny electrical pulses to the right and left ventricles through three leads (flexible insulated wires) that are inserted through the veins to the heart. The purpose of this study is to evaluate a new lead for delivering energy to the left ventricle (bottom left chamber of the heart).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
20066 Lead
Arm Type
Experimental
Arm Description
Non-randomized study. Intervention: Device: Pacing Lead
Intervention Type
Device
Intervention Name(s)
Pacing Lead
Intervention Description
Implant and follow up of Model 20066 lead
Primary Outcome Measure Information:
Title
Number of implant procedure related and lead-related complications in the first month post-implant
Time Frame
One Month
Secondary Outcome Measure Information:
Title
Success rate of the Model 20066 lead
Time Frame
Within 24 hours of procedure initiation
Title
Cannulation time
Time Frame
Within 24 hours of procedure initiation
Title
Fluoroscopy Time
Time Frame
Within 24 hours of procedure initiation
Title
Model 20066 Lead Placement Time
Time Frame
Within 24 hours of procedure initiation
Title
Total Implant Time
Time Frame
Within 24 hours of procedure initiation
Title
Assessment of Lead Handling Characteristics
Time Frame
Within 24 hours of procedure initiation
Title
Electrical Performance-Tip Electrode: LV Voltage Threshold
Time Frame
12-month
Title
Electrical Performance -Tip Electrode: Sensing
Time Frame
12-month
Title
Electrical Performance -Tip Electrode: Pacing Impedance
Time Frame
12-month
Title
Electrical Performance -Ring Electrode: LV Voltage Threshold
Time Frame
12-month
Title
Electrical Performance -Ring Electrode: Sensing
Time Frame
Within 24 hours of procedure initiation
Title
Electrical Performance -Ring Electrode: Pacing Impedance
Time Frame
12-month
Title
Summarize All Adverse Events
Time Frame
12-month
Title
Summarize Final 20066 Lead Position
Time Frame
Within 24 hours of procedure initiation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient meets CRT inclusion criteria as determined by local regulatory and/or hospital policy Patient has signed and dated the study-specific informed consent form Patient is 18 years of age or older Patient is expected to remain available for follow-ups at the investigational center Patient is willing and able to comply with protocol Exclusion Criteria: Patient has a previous complete atrial based biventricular CRT system Patient has a previous LV lead implanted or previous implant attempt within 30 days of implant or ongoing Adverse Events from previous unsuccessful attempt Patient has known coronary venous vasculature that is inadequate for lead placement Patient has unstable angina pectoris or has had an acute myocardial infarction (MI) within the past month Patient has had a coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the past three months Patient has chronic (permanent) atrial arrhythmias Patient has contraindications for standard transvenous cardiac pacing (e.g., mechanical right heart valve) Patient has had a heart transplant (patients waiting for heart transplants are allowed in the study) Patient is enrolled in any concurrent drug and/or device study that may confound the results of this study Patient has a terminal illness and is not expected to survive more than three months Patient meets exclusion criteria required by local law (e.g. age, incompetence, pregnancy, breast feeding, etc). Patient is unable to tolerate an urgent thoracotomy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Raymond Yee, MD
Organizational Affiliation
London Health Sciences Centre, London, Ontario, Canada
Official's Role
Principal Investigator
Facility Information:
City
London
Country
Canada
City
Newmarket
Country
Canada
City
Kuala Lumpur
Country
Malaysia
City
Stockholm
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
24801899
Citation
Yee R, Gadler F, Hussin A, Bin Omar R, Khaykin Y, Verma A, Lazeroms M, Hine DS, Marquard KR. Novel active fixation mechanism permits precise placement of a left ventricular lead: early results from a multicenter clinical study. Heart Rhythm. 2014 Jul;11(7):1150-5. doi: 10.1016/j.hrthm.2014.04.020. Epub 2014 May 4.
Results Reference
result

Learn more about this trial

Model 20066 Left Ventricular (LV) Lead Study

We'll reach out to this number within 24 hrs